Simbol EVFM | |
Simbol | EVFM |
Simbol eToro | EVFM |
MarketWatch | EVFM |
Finviz | EVFM |
Yahoo Finance | EVFM |
Google Finance | EVFM |
TradingView | EVFM |
Investing.com | EVFM |
Denumire | Evofem Biosciences Inc. |
Website | evofem.com |
Piața | NASDAQ |
ISIN | US30048L2034 |
Sector | Health Technology |
Industrie | Biotechnology |
Monedă | USD |
Preț | 0,6301 USD |
Capitalizare bursieră | 0,002 mld. USD |
Beta | 0,9153 |
EPS | -589,5462 |
Profit anual | -99,39% |
Dată actualizare | 20.07.2023 |
Descriere |
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
19.09.2021 | 0,00 | 0,9068 | 0,130 | 0,00% | 0,0000 | -63,93% | $0,00 |
06.12.2022 | 0,00 | 1,0241 | 0,007 | 0,00% | -19,5502 | -99,14% | $0,05 |
16.06.2023 | 0,00 | 1,0000 | 0,002 | 0,00% | -819,1100 | -97,71% | $0,92 |
20.07.2023 | 0,00 | 0,9153 | 0,002 | 0,00% | -589,5462 | -99,39% | $0,63 |